Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain

Molecular and Cellular Biology

Volumn 20, Issue 20, 2000, Pages 7735-7750

  Fiorentino, L ^a   Pertica, C ^a   Fiorini, M ^a   Talora, C ^a   Crescenzi, M ^a   Castellani, L ^a   Alema, S ^a   Benedetti, P ^a   Segatto, O ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; REGULATOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CELL TRANSFORMATION; CONTROLLED STUDY; MITOGENESIS; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMAL; BREAST NEOPLASMS; CATALYTIC DOMAIN; CELL CYCLE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MITOGENS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; PROTEINS; RATS; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; SUPPORT, NON-U.S. GOV'T; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0033796072     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.20.7735-7750.2000     Document Type: Article

References (83)

1. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
2. Role of GGF/neuregulin signaling in interactions between migrating neurons and radial gila in the developing cerebral cortex
3. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired
4. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities
5. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway
6. Mona, a novel hematopoietic-specific adaptor interacting with the macrophage colony-stimulating factor receptor, is implicated in monocyte/macrophage development
7. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system
8. The proto-oncogene c-Cbl is a negative regulator of DNA synthesis initiated by both receptor and cytoplasmic tyrosine kinases
9. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface
10. Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways
11. Sprouty, an intracellular inhibitor of Ras signaling
12. High-efficiency transformation of mammalian cells by plasmid DNA
13. Rat gene 33: Analysis of its structure, messenger RNA and basal promoter activity
14. C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains
15. Opposing actions of CSW and RasGAP modulate the strength of Torso RTK signaling in the Drosophila terminal pathway
16. Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation
17. ErbB-2 is a potent oncogene when overexpressed in NIH/ 3T3 cells
18. The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity
19. Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma
20. Specific growth response of ras-transformed embryo fibroblasts to tumour promoters
21. The neu-oncogene: Signal transduction pathways, transformation mechanisms and evolving therapies
22. ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2- and heregulin-deficient mice
23. Transformation of NIH3T3 cells by Rous sarcoma virus occurs with high efficiency in the absence of proviral rearrangements or amplification
24. The erbB-2 mitogenic signaling pathway: Tyrosine phosphorylation of phospholipase C-γ and GTPase-activating protein does not correlate with erbB-2 mitogenic potency
25. The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis
26. Quantitative variations in the level of MAPK activity control patterning of the embryonic termini in Drosophila
27. Synthetic peptides corresponding to the site phosphorylated in 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as substrates of cyclic nucleotide-dependent protein kinases
28. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases
29. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases
30. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
31. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling
32. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein
33. Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
34. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts
35. Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma 1 signaling pathway
36. Receptor signaling: When dimerization is not enough
37. The tyrosine kinase negative regulator c-Cbl as a RING-type. E2-dependent ubiquitin-protein ligase
38. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer
39. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
40. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms
41. Requirement for neuregulin receptor erbB2 in neural and cardiac development
42. Molecular cloning and analysis of full-length cDNAs cognate to a rat gene under multihormonal control
43. Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers
44. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
45. Surface distribution and internalization of erbB-2 proteins
46. A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42
47. All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor
48. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
49. SH3 domains. Minding your p's and q's
50. The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: Comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes
51. Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells. Liver-specific induction patterns of gene 33, phosphoenolpyruvate carboxykinase, and the jun, fos, and egr families
52. Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development
53. Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice
54. Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: Oligomerization of kinase domains
55. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction
56. ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner
57. Protein-protein interactions define specificity in signal transduction
58. Signaling through scaffold, anchoring, and adaptor proteins
59. Production of high-titer helper-free retroviruses by transient transfection
60. Negative feedback mechanisms and their roles during pattern formation
61. Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors
62. Casein kinase 2: An 'eminence grise' in cellular regulation?
63. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
64. PEST sequences and regulation by proteolysis
65. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase
66. Specificity within the EGF family/ErbB receptor family signaling network
67. Src-like adaptor protein (Slap) is a negative regulator of mitogenesis
68. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1
69. An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: Evidence for a ret-specific signaling pathway
70. Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene
71. The role of autophosphorylation in modulation of erbB-2 transforming function
72. The juxtamembrane regions of the epidermal growth factor receptor and gp185(erbB-2) determine the specificity of signal transduction
73. Shc products are substrates of erbB-2 kinase
74. From Src homology domains to other signaling modules: Proposal of the 'protein recognition code'
75. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo
76. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/ neuregulin and epidermal growth factor
77. Control of EGF receptor signaling by clathrin-mediated endocytosis
78. Mammalian Ras interacts directly with the serine/threonine kinase Raf
79. Alternative intracellular routing of ErbB receptors may determine signaling potency
80. Identification of a novel mitogen-inducible gene (mig-6): Regulation during G1 progression and differentiation
81. Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements
82. The structural basis for 14-13-3: Phosphopeptide binding specificity
83. Cloning and characterization of a novel Cdc42-associated tyrosine kinase. ACK-2, from bovine brain